Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 161,791 |
|
|||||
| News | - | ||||||
| Day High | 4.78 | Low High |
|||||
| Day Low | 4.11 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Marker Therapeutics Inc | MRKR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.7653 | 18.38% | 4.93 | 10:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.18 | 4.11 | 4.78 | 4.78 | 4.1647 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,078 | 161,791 | US$ 4.48 | US$ 725,093 | - | 2.40 - 9.6799 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:59:16 | formt | 268 | US$ 4.93 | USD |
Marker Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 42.49M | 8.89M | - | 3.31M | -8.24M | -0.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Marker Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 13/6/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18/5/2024 | 08:25 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 16/5/2024 | 06:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16/5/2024 | 06:03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 08/4/2024 | 21:00 | GlobeNewswire Inc. | Principal Investigator from City of Hope National Medical.. |
| 26/3/2024 | 08:45 | GlobeNewswire Inc. | Marker Therapeutics Reports Year-End 2023 Corporate and.. |
| 23/3/2024 | 03:30 | GlobeNewswire Inc. | Marker Therapeutics to Present at the H.C. Wainwright 2nd.. |
| 02/3/2024 | 00:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 26/2/2024 | 23:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/1/2024 | 23:30 | GlobeNewswire Inc. | Marker Therapeutics Receives Approval from United States.. |
| 09/1/2024 | 00:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/1/2024 | 00:24 | GlobeNewswire Inc. | Marker Therapeutics Announces Clinical Program Updates and.. |
Historical MRKR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.54 | 4.78 | 3.3835 | 3.79 | 32,795 | 1.39 | 39.27% |
| 1 Month | 4.22 | 4.78 | 3.33 | 3.80 | 16,646 | 0.71 | 16.82% |
| 3 Months | 4.91 | 4.93 | 3.33 | 4.20 | 16,318 | 0.02 | 0.41% |
| 6 Months | 4.69 | 6.1568 | 3.33 | 4.43 | 21,812 | 0.24 | 5.12% |
| 1 Year | 3.13 | 9.6799 | 2.40 | 5.11 | 70,380 | 1.80 | 57.51% |
| 3 Years | 33.00 | 34.40 | 0.6706 | 7.49 | 479,112 | -28.07 | -85.06% |
| 5 Years | 63.00 | 91.70 | 0.6706 | 18.86 | 637,413 | -58.07 | -92.17% |
